Literature DB >> 6887392

Sarcomatoid renal carcinoma.

K M Tomera, G M Farrow, M M Lieber.   

Abstract

Sarcomatoid renal carcinoma made up 1 per cent of renal parenchymal tumors resected from 1967 to 1980. The majority of patients with this aggressive type of renal carcinoma were symptomatic and had a palpable renal mass at the time of diagnosis. Only 2 of 13 patients had tumor confined within the renal capsule at the time of operation. One of these patients survived and 12 of 13 died rapidly of metastatic renal carcinoma, with a median survival of 6.3 months from the time of diagnosis. This distinctive histologic variant of renal carcinoma has a highly malignant biological behavior and, as effective adjuvant treatment for renal carcinoma becomes available, should be one of the tumor types treated vigorously.

Entities:  

Mesh:

Year:  1983        PMID: 6887392     DOI: 10.1016/s0022-5347(17)51388-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

1.  Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?

Authors:  Brian Shuch; Jonathan Said; Jeff C La Rochelle; Ying Zhou; Gang Li; Tobias Klatte; Fairooz F Kabbinaavar; Allan J Pantuck; Arie S Belldegrun
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

2.  Spontaneous intraperitoneal rupture of pyonephrosis in a patient with unknown kidney carcinosarcoma: a case report.

Authors:  Silvia Quaresima; Antonio Manzelli; Edoardo Ricciardi; Athanasios Petrou; Nicholas Brennan; Alessandro Mauriello; Piero Rossi
Journal:  World J Surg Oncol       Date:  2011-04-12       Impact factor: 2.754

3.  Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy.

Authors:  Brian Shuch; Jonathan Said; Jeffrey C LaRochelle; Ying Zhou; Gang Li; Tobias Klatte; Frederic Pouliot; Fairooz F Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

Review 4.  Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies.

Authors:  Brian Shuch; Gennady Bratslavsky; W Marston Linehan; Ramaprasad Srinivasan
Journal:  Oncologist       Date:  2012-01-10

5.  Primary renal osteosarcoma: A case report and review of literature.

Authors:  Farshad Namdari; Mohammad Javad Nazar Pour; Arya Behzadi; Mona Akbari; Hedieh Moradi; Hossein Dialameh
Journal:  Clin Case Rep       Date:  2022-06-15

6.  Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta2-microglobulin genes.

Authors:  Chin-Hsuan Hsieh; Ya-Jan Hsu; Chien-Chung Chang; Hsin-Chun Liu; Kun-Lung Chuang; Cheng-Keng Chuang; See-Tong Pang; Kenichiro Hasumi; Soldano Ferrone; Shuen-Kuei Liao
Journal:  Cancer Immunol Immunother       Date:  2008-08-15       Impact factor: 6.968

7.  Summary of the first annual Genitourinary Medical Oncology Conference Renal Cell Carcinoma Forum.

Authors:  Lori A Wood; Bernard Escudier; Neil Reaume
Journal:  Can Urol Assoc J       Date:  2007-06       Impact factor: 1.862

8.  Impact of histology on the treatment outcome of metastatic or recurrent renal cell carcinoma.

Authors:  J Wu; G Caliendo; X P Hu; J P Dutcher
Journal:  Med Oncol       Date:  1998-04       Impact factor: 3.064

Review 9.  MRI phenotype in renal cancer: is it clinically relevant?

Authors:  Naomi Campbell; Andrew B Rosenkrantz; Ivan Pedrosa
Journal:  Top Magn Reson Imaging       Date:  2014-04

Review 10.  Prognostic factors for biologic therapy in kidney cancer.

Authors:  Beverly J Drucker
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.